US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 269 actively recruiting studies with Colorado sites out of 269 registered in total. The busiest research areas in Colorado are Breast Cancer, Aging, Solid Tumor. Leading sponsors running trials in the state include University of Colorado, Denver, Pfizer, AstraZeneca. By stage, Colorado trials break down as Phase 1 (56), Phase 2 (76), Phase 3 (78), Phase 4 (12).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
269
Recruiting Now
269
← Back to US Map
Top Conditions in Colorado
Breast Cancer (5)Aging (4)Solid Tumor (4)Multiple Myeloma (4)Non-Small Cell Lung Cancer (4)Pancreatic Cancer (3)Solid Tumor, Adult (3)Colorectal Neoplasms (3)Urothelial Carcinoma (3)Type 1 Diabetes (3)Cardiovascular Diseases (3)Overweight (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 269 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 269. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Aging, Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT05065372 Phase 1
Recruiting
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Va...
Condition
Type 1 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Kalie Tommerdahl
View Trial →
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
View Trial →
NCT01904851 N/A
Recruiting
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Condition
Peripheral Arterial Disease
Enrollment
14,000 pts
Location
United States
Sponsor
Baylor Research Institute
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT07120295 Phase 4
Recruiting
Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Ac...
Condition
Bile Duct Adenocarcinoma
Enrollment
75 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT03674372 N/A
Recruiting
Fetoscopic Endoluminal Tracheal Occlusion
Condition
Congenital Diaphragmatic Hernia
Enrollment
10 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06940739 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanc...
Condition
Unresectable Melanoma
Enrollment
42 pts
Location
United States, Australia
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT04907396 N/A
Recruiting
International Weight Control Registry
Condition
Weight Loss
Enrollment
100,000 pts
Location
United States
Sponsor
Tufts University
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07297823 N/A
Recruiting
Sex Differences in Cold-Induced Changes in Maximal Fat Oxidation
Condition
Exercise
Enrollment
20 pts
Location
United States
Sponsor
Colorado State University
View Trial →
NCT07196748 Phase 3
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Mode...
Condition
Colitis, Ulcerative
Enrollment
882 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, China, France
Sponsor
Stoke Therapeutics, Inc
View Trial →
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT07652658 Phase 2
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
359 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT04910685 Phase 2, Phase 3
Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Pati...
Condition
Indolent Systemic Mastocytosis
Enrollment
534 pts
Location
United States, Argentina, Australia
Sponsor
Blueprint Medicines Corporatio
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
View Trial →
NCT04192344 Phase 1
Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in ...
Condition
Neoplasms
Enrollment
276 pts
Location
United States, China
Sponsor
Abbisko Therapeutics Co, Ltd
View Trial →
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
View Trial →
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07673744 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following...
Condition
Myasthenia Gravis
Enrollment
120 pts
Location
United States
Sponsor
TG Therapeutics, Inc.
View Trial →
NCT07424365 N/A
Recruiting
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in He...
Condition
Mild Cognitive Impairment (MCI)
Enrollment
80 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
Page 3 of 11 — 269 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology